View 
FILTERS (0)
* Not connected to ResearchPool

MORE FILTERS

  
reports

First Financial Corporation Ind: 1 director

A director at First Financial Corporation Ind bought 531 shares at 38.060USD and the significance rating of the trade was 51/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last tw...

Green Brick Partners Inc: 1 director

A director at Green Brick Partners Inc sold 40,000 shares at 56.770USD and the significance rating of the trade was 81/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two year...

Hwa Fong Rubber(Thailand) Public Company Limited: 1 director

A director at Hwa Fong Rubber(Thailand) Public Company Limited sold 4,000,000 shares at 4.200THB and the significance rating of the trade was 84/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's direct...

ABGSC Financials Research ... (+3)
  • ABGSC Financials Research
  • Jan Erik Gjerland
  • Patrik Brattelius

Steady delivery usually gets a reward

Q1'24: adj. PTP +4% vs cons / +0% vs ABGSCe (better NII, softer fee). Reiterate guidance'25 lending NOK 15bn and ROE to 10-12%. Consensus could come up 1-3% for 24e- 25e; stock up 1-3%.

ABGSC Healthcare Research ... (+2)
  • ABGSC Healthcare Research
  • Morten Larsen
Konrad Zomer
  • Konrad Zomer

Adecco : Doing relatively OK in a tough market environment

>Adecco just about meets consensus, underlying performance actually good - Adecco reported Q1 results which were broadly in line with consensus. Organic revenue growth came in flat (css at -1.3%, we at -1.2%), with the gross margin at 19.8%. This is a full 100bps yoy decline, mainly because of a change in business mix as pricing was referred to by management as firm. The temp gross margin had a negative effect of 50bps, permanent placement had a negative 40bps impact ...

Chaima Ferrandon ... (+2)
  • Chaima Ferrandon
  • Sven Edelfelt

Heidelberg Materials : Rien ne sert de courir

>EBITDA en ligne avec le consensus - Heidelberg Materials a publié un EBITDA T1 2024 en ligne avec les attentes. L’EBITDA ressort à 542 M€ en baisse de 2.6% en réel et de 2.4% à pcc (consensus de la société à 535 M€, soit 1% au-dessus). Le groupe a été pénalisé par la baisse des volumes de 202 M€ au niveau de l’EBITDA (CA en dessous des attentes de 6%), presque compensée par, le différentiel prix/coûts de +189 M€ après +218 M€ au T4, +453 M€ au T3 et 140 M€ au T2. La ...

Benoit Valleaux ... (+5)
  • Benoit Valleaux
  • Roland Pfaender
  • MBA
  • CFA
  • CCRA

Coface : Bon début d’année, avec un ratio combiné qui reste excellent

>Baisse des revenus comme attendu, mais avec un meilleur mix d’activités - Coface a publié hier soir son RN du T1 2024, qui a été supérieur aux attentes. Les revenus du groupe ont été de 464 M€ au T1 2024, en baisse de 2.4% en publié et de 1.6% à données comparables, en ligne avec les attentes, mais avec des primes d’assurance moindres qu’attendu et des revenus des autres activités (dont l’information) meilleures qu’anticipé. Les revenus d’assurance-crédit ont baissé ...

Benoit Valleaux ... (+5)
  • Benoit Valleaux
  • Roland Pfaender
  • MBA
  • CFA
  • CCRA

SCOR : Solid Q1 results expected despite cautious provisioning

>Strong premium growth and net income expected at € 192m - Scor is due to publish its Q1 2024 results on 17 May. We forecast gross written premiums of € 5.1bn, up 6.7%, with strong growth in P&C (+11% l-f-l), following on the from the solid renewals in January, and much more moderate growth in life reinsurance (+2% l-f-l). Given the decline in written P&C premiums last year, we should see growth of a little over 2% in insurance revenues (+3.5%e in P&C, +1.2%e in life...

Christophe Chaput
  • Christophe Chaput

Beneteau : Strong drop in Q1 sales, as expected, due to inventory redu...

>Q1 sales down 26.9% to € 348.7m (ODDO BHF: € 384.4m est.) - The Bénéteau group reported Q1 sales down 27.1% to € 348.7m, a more pronounced decline than we expected (our estimate € 384.4m; difference -9%). By division, this slowdown in sales in Q1 is attributable to: 1/ A strong fall in boat sales of 39% to € 228.7m (ODDO BHF: € 281.3m) due to a high base of comparison (Q1 2023 boat sales: +57%) as well as inventory drawdowns at distributors. By segment, we note...

 PRESS RELEASE

Virtualware and the Centre for Integrated Transportation and Mobility ...

Virtualware and the Centre for Integrated Transportation and Mobility partner to introduce VIROO platform for design review in transportation sector Bilbao, Spain, April 7 , 2024.- Virtualware (EPA: MLVIR), the European leader in virtual reality has signed a partnership agreement with the business accelerator for innovators in the smart, connected and electrified transportation sector, the Centre for Integrated Transportation and Mobility  to introduce  into the transportation market. CITM, supported by Innovation Factory and funded through the Ontario Vehicle Innovation Network (OVIN) is ...

Atlassian Corp: 2 directors

A director at Atlassian Corp sold 8,241 shares at 183.507USD and the significance rating of the trade was 68/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clearly ...

Utz Brands Inc: 2 directors

A director at Utz Brands Inc sold 20,103 shares at 19.469USD and the significance rating of the trade was 57/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clearly ...

ABGSC Shipping & Transport Research ... (+3)
  • ABGSC Shipping & Transport Research
  • Oliver Dunvold
  • Petter Haugen

Much as expected

Q1'24 EBITDA of USD 38m, TCE pre-announced. Q2'24 average fleet TCE earnings in-line with ABGSCe. Much as expected, stock flat today.

Christophe Chaput ... (+2)
  • Christophe Chaput
  • Hela Zarrouk

Elis : A strong start to the year with Q1 organic growth at 6.4% (5.8%...

>Q1 sales slightly ahead of expectations: € 1,092.4m vs € 1,076.4m estimated - For its Q1, the Elis group has reported sales a shade above forecasts. Sales were up 7.8% to € 1,902.4m whereas we looked for € 1,076.4m (gap +1.5%) and the consensus of € 1,079.8m. At constant scope and forex, growth stands at 6.4%, which is a strong performance (+5.8% estimated, consensus +5.5%), noting that the group benefited in Q1 from a favourable calendar effect of around +0.5%. As f...

 PRESS RELEASE

EQS-News: Elmos: Positive start into the new fiscal year – guidance fo...

EQS-News: Elmos Semiconductor SE / Key word(s): Quarter Results Elmos: Positive start into the new fiscal year – guidance for 2024 confirmed 07.05.2024 / 07:40 CET/CEST The issuer is solely responsible for the content of this announcement. Sales up by 4.5% to 136.8 million Euro in the first quarter of 2024 – EBIT margin reaches 24.7% Dortmund, May 7, 2024: Elmos Semiconductor SE (FSE: ELG) has made a positive start into the new fiscal year and generated Group sales of 136.8 million Euro in the first quarter of 2024, representing sales growth of 4.5% year on year (Q1 2023...

 PRESS RELEASE

EQS-News: Elmos: Positiver Start in das neue Geschäftsjahr – Prognose ...

EQS-News: Elmos Semiconductor SE / Schlagwort(e): Quartalsergebnis Elmos: Positiver Start in das neue Geschäftsjahr – Prognose 2024 bestätigt 07.05.2024 / 07:40 CET/CEST Für den Inhalt der Mitteilung ist der Emittent / Herausgeber verantwortlich. Umsatz steigt im ersten Quartal 2024 um 4,5% auf 136,8 Mio. Euro – EBIT-Marge erreicht 24,7% Dortmund, 7. Mai 2024: Die Elmos Semiconductor SE (FSE: ELG) ist positiv in das neue Geschäftsjahr gestartet und erzielte im ersten Quartal 2024 mit einem Konzernumsatz von 136,8 Mio. Euro ein Umsatzwachstum von 4,5% gegenüber dem Vorjah...

Indie Semiconductor Inc: 1 director

A director at Indie Semiconductor Inc sold 60,000 shares at 5.680USD and the significance rating of the trade was 51/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years ...

Arnaud Autier ... (+2)
  • Arnaud Autier
  • Pierre Tegner

Rémy Cointreau : Rencontre entre Emmanuel Macron et Xi Jinping : échan...

>Surperformance maintenue avec un OC inchangé à 125 € - Nous maintenons notre opinion Surperformance avec un OC inchangé à 125 €. La valorisation du titre reste attrayante à 24x de PE NTM, en absolu comme en relatif, pour un titre aux fondamentaux de qualité et qui devrait renouer avec la croissance courant FY 24/25e.Le journal Les Echos a publié hier un article intitulé « Xi Jinping promet à Emmanuel Macron d'épargner le cognac français » après une entrevue entr...

Dominic Rose ... (+2)
  • Dominic Rose
  • Naresh Chouhan

Destiny Pharma - XF-73 Nasal Readying For Phase III (Sponsored Researc...

With Destiny yet to strike a deal for XF-73 Nasal that would deliver sufficient value for shareholders, they have issued a strategic update to the market. The top priority is to advance XF-73 Nasal into Phase III studies, which they want to achieve by 2025. While a licensing deal is one possible route, the company is also considering a self-funded option. However, in the meantime, the Phase III study has been redesigned to address feedback from potential partners, cutting the projected cost by o...

Loading...
New interest

Save your current filters as a new Interest

Please enter a name for this interest

Email alerts

Would you like to receive real-time email alerts when a new report is published under this interest?

Save This Search

These search results will show up under 'Saved searches' in the left panel

Please enter a name for this saved search

ResearchPool Subscriptions

Get the most out of your insights

Get in touch